Letter to the editor: new response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor
Gastric Cancer
.
2021 Nov;24(6):1374-1375.
doi: 10.1007/s10120-021-01246-w.
Epub 2021 Sep 5.
Authors
Junjie Jiang
1
,
Lisong Teng
2
Affiliations
1
Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
2
Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
[email protected]
.
PMID:
34482433
DOI:
10.1007/s10120-021-01246-w
No abstract available
Publication types
Letter
Comment
MeSH terms
Benzamides
Gastrointestinal Stromal Tumors* / drug therapy
Humans
Imatinib Mesylate / therapeutic use
Piperazines
Stomach Neoplasms*
Substances
Benzamides
Piperazines
Imatinib Mesylate